ESMO 2026 INTELLIGENCE · MADRIDKnow what top breast cancer KOLs think about your drug — before, during and after ESMO. Six seats only.Request the brochure →
GRG Health Talk to our team
Who We Serve

Built for the people who stake decisions on research.

Pharma & Life Sciences

From pipeline to launch to loss of exclusivity: qual, quant, expert consultations, advisory boards, and always-on intelligence — every respondent verified before the first question.

Talk to our team →

Medtech & Clinical AI

Surgeons, interventionalists, lab directors, procurement leaders: the hardest audiences, reached with confidence — because we recruited them personally.

Talk to our team →

Agencies & Consulting

Built to power agencies; the client relationship stays yours, always. Verified respondents, rapid feasibility, delivery teams that work as an extension of yours.

Talk to our team →

Funds & Investors

Diligence-grade clinical and commercial insight. Rapid expert access for theses that can't wait; structured research for the ones that shouldn't.

Talk to our team →

Frequently asked, honestly answered.

Who verifies your respondents?+
We do — six layers, including human license checks against official registries and biometric liveness.
Will we know who the respondents are?+
You'll know exactly what they are — specialty, role, market, screening — never who. Trust is built on methodology — recruitment, moderation, six-layer verification — never on exposing identities.
Which geographies and languages?+
56+ countries, 12+ languages, in-market human recruitment where needed.
How fast can a study launch?+
Digital-first studies in days; qualitative as a seven-day workflow through SETHI.
Are you compliant?+
ISO 20252:2019 and ISO 27001:2022 certified; members of EPHMRA, Intellus, ESOMAR, AQR, and BHBIA; GDPR-aligned; pharmacovigilance-ready. Glad to complete security questionnaires.
Do you work with agencies as well as pharma?+
Yes — worldwide. The client relationship stays yours, always.